文献速递肝胆胰外科围术期管理与 ERAS

血液透析患者胰十二指肠切除术后死亡与并发症风险分析

Mortality and morbidity after pancreatoduodenectomy in patients undergoing hemodialysis: Analysis using a national inpatient database.
PubMed 文献 · Surgery · 2018-11-10

基于日本全国住院数据库的倾向性评分匹配分析,比较透析与非透析患者胰十二指肠切除术后的结局。共纳入30495例患者,其中307例(1.0%)接受血液透析。匹配后透析患者术后并发症、30天及90天死亡风险均显著升高。

要点

  • 透析患者胰十二指肠切除术后并发症风险增加(OR 1.62)。
  • 透析患者30天死亡风险显著升高(OR 7.45)。
  • 透析患者90天死亡风险显著升高(OR 10.9)。

核心结论

  • 血液透析患者胰十二指肠切除术后并发症和死亡风险显著增加。
  • 外科医生应特别关注透析患者术后腹腔出血、腹膜炎、脓毒症或DIC及急性冠脉事件的风险。

研究设计与样本

  • 利用日本诊断程序组合全国住院数据库,识别2010年7月至2015年3月期间接受胰十二指肠切除术的患者。
  • 共纳入30495例 eligible 患者,其中307例(1.0%)接受血液透析。
  • 采用倾向性评分1:4匹配,匹配后共1535例,包括307例透析患者和1228例非透析患者。

临床怎么用

  • 对接受胰十二指肠切除术的血液透析患者,应充分评估并告知术后并发症和死亡风险显著增高。
  • 术后管理应重点监测腹腔出血、腹膜炎、脓毒症或DIC及急性冠脉事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether patients undergoing hemodialysis have greater risks of mortality and morbidity after pancreatoduodenectomy remains unknown. METHODS: We used the Diagnosis Procedure Combination database, a national Japanese inpatient database, to identify patients who underwent pancreatoduodenectomy from July 2010 to March 2015. We conducted propensity-score-matching analyses to compare the outcomes, including postoperative complications and 30- and 90-day mortality after pancreatoduodenectomy between patients with and without hemodialysis. RESULTS: Of 30,495 eligible patients, 307 (1.0%) received hemodialysis. In the unmatched cohort, the proportions of male sex, younger age, pancreatic cancer, ischemic heart disease, diabetes mellitus, and hypertension were greater in patients with hemodialysis than those without hemodialysis. A 1-to-4 propensity score matching created a total of 1,535 patients, including 307 with hemodialysis and 1,228 without hemodialysis. Patients undergoing hemodialysis had greater proportions of postoperative complications, including peritonitis (8.8% vs 4.8%, P = .012), sepsis or disseminated intravascular coagulation (3.6% vs 0.7%, P = .001), intra-abdominal bleeding (4.9% vs 0.7%, P < .001), and acute coronary event (4.2% vs 1.7%, P = .015). Propensity score matching showed that patients undergoing hemodialysis had an increased risk of postoperative complications (OR, 1.62; 95% CI, 1.23-2.14; P = .001), 30-day mortality (OR, 7.45; 95% CI, 3.26-17.0; P < .001), and 90-day mortality (OR, 10.9; 95% CI, 6.58-18.2; P < .001) than those not undergoing hemodialysis. CONCLUSION: Patients undergoing hemodialysis had a significantly increased risk of postoperative complications and death after pancreatoduodenectomy. In particular, surgeons should consider the increased risk of intra-abdominal bleeding, peritonitis, sepsis or disseminated intravascular coagulation, and acute coronary event in patients with hemodialysis.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Shinkawa H, Yasunaga H, Hasegawa K, et al. Mortality and morbidity after pancreatoduodenectomy in patients undergoing hemodialysis: Analysis using a national inpatient database. Surgery. 2018. PMID: 30424925. doi:10.1016/j.surg.2018.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。